Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Chronus Health

Request full access

Portable platform for real-time diagnosis at the point-of-care providing lab results in minutes, dramatically improving patient outcomes

Fremont, United StatesFounded 2017Biotech & Life Sciences

About Chronus Health

Chronus Health, established in 2017 by co-founders Anand Parikh and Ashish Jagtiani, is a medical technology company focused on the point-of-care diagnostics market. The inspiration for the company came from Jagtiani's personal experience with his sister's leukemia diagnosis, where he observed the frustratingly long wait times for blood test results. This led him, a PhD with a background in semiconductor devices and lab-on-a-chip technology from his time at IBM's Thomas J. Watson Research Center, to envision a faster solution. He partnered with his long-time friend, Anand Parikh, a bioengineering graduate with extensive experience in medical devices, to launch the company.

The company is developing a portable, real-time blood testing system designed to deliver lab-quality results within minutes, directly at the point of care. Chronus Health's platform operates similarly to a glucose meter, utilizing a disposable test cartridge with embedded sensors. This system sidesteps the complex and costly optical measurements of traditional, bulky blood analyzers by employing a proprietary electrical sensing approach that combines microfluidics, semiconductors, and machine learning. This enables the device to perform a wide range of tests, including complete blood counts (CBC), complete metabolic panels (CMP), chemistry assays, and immunoassays, on-site. By providing immediately actionable data, the technology aims to significantly reduce diagnosis time, improve patient outcomes, and lower overall healthcare costs.

Chronus Health targets its services toward healthcare settings where rapid blood analysis is critical but often unavailable, such as urgent care centers, skilled nursing facilities, infusion centers, retail clinics, and primary care practices. The business model centers on providing a low-cost, compact system that can handle the majority of common blood tests, challenging the market's reliance on centralized labs for analysis. The company has secured significant financial backing, raising a total of $23.6 million over four funding rounds. Its most recent major funding was a $22 million Series A round in January 2022, led by Tarsadia Investments with participation from Monta Vista Capital, SOSV, and Savantus Ventures.

Source: Dealroom company data

At a glance

Status
Operational
Employees
4
Open positions
None listed
Dealroom signal
62.2/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Testing, Biotechnology, Microfluidics, Point of Care, Biotech and Pharma, medical testing, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
DEBT✓Debt Jan 2024 $5M — Undisclosed ↗
SERIES A✓Equity / VC Jan 2022 $22M $88M Tarsadia Investments · SOSV · Monta Vista Capital · Savantus Ventures ↗
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Chronus Health website traffic

Latest recorded traffic for Chronus Health is 110 monthly website visits, down 83.1% over the last three months. Chronus Health's team declined 20% over the past year.

Latest monthly visits110 3-month web change-83.1% 1-year team growth-20%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
KirkstallAdvanced organ-on-a-chip dynamic cell culture systems York, United Kingdom Acquired 20 $923K $1.3M
Lighthouse BiotechProviding oncological and pharmaceutical research with access to pure, viable, and individually isolated cancer cells to advance precision medicine Pordenone, Italy Operational
React4lifeOrgan-on-chip solution to improve the development of new drugs and reduce the use of animals for trials Genoa, Italy Operational
Bi/ond SolutionsEmpowers biological innovation by engineering hardware solutions for cell-based assays Delft, Netherlands Closed
River BioMedicsBiotech company that aims to develop human 3d in vitro 3d human heart tissue for pre-clinical drug testing Enschede, Netherlands Operational
Group K DiagnosticsDeveloping a point-of-care diagnostic device that leverages paper-based microfluidics technology to reduce cost and time of testing for over 40 diseases Philadelphia, United States Operational
Paratus DiagnosticsParatus Diagnostics is developing a portfolio of point-of-care diagnostic devices that will make healthcare San Marcos, United States Operational
EmulateA privately held company that creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health Boston, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Chronus Health in the Fremont ecosystem

Live from Dealroom

The Chronus Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

Series A3 investors entered at this stage

  • Tarsadia Investments
  • Monta Vista Capital
  • Savantus Ventures

Other known investors5 additional known investors

  • Indie Bio
  • Fogarty Institute of Innovation
  • Harbor Street Ventures
  • Plug and Play
  • SeedFolio
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Chronus Health on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Chronus Health’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.